Synthesis of LHRH antagonists suitable for oral administration via the vitamin B12 uptake system.
Conjugates have been synthesized between vitamin B12 and two lysyl derivatives of the LHRH antagonist, ANTIDE. Lys6-ANTIDE and Lys8-ANTIDE were both found to have similar activities to the native analogue in the in vitro pituitary cell assay. The in vitro bioactivity of the VB12-ANTIDE conjugates was preserved following linkage using a number of spacers; however, the in vivo bioactivity was lost. In order to produce conjugates which had similar in vivo bioactivity to the native analogue, it was necessary to link the VB12 to the ANTIDE analogues using thiol cleavable spacers. The resultant conjugates had similar activity to ANTIDE both in vitro and in vivo and were also found to be much more water soluble than ANTIDE. These VB12-ANTIDE conjugates show potential utility as water soluble ANTIDE analogues for parenteral use and are protease resistant LHRH antagonist analogues suitable for uptake from the intestine via the VB12-transport system following oral administration.
Russell-Jones
G J
GJ
Biotech Australia Pty Ltd, Roseville, NSW.
Westwood
S W
SW
Farnworth
P G
PG
Findlay
J K
JK
Burger
H G
HG
D000284:Administration, Oral; D000595:Amino Acid Sequence; D000818:Animals; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D007986:Luteinizing Hormone / Q000097:blood / Q000187:drug effects; D008297:Male; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013329:Structure-Activity Relationship; D014805:Vitamin B 12 / Q000737:chemistry / Q000493:pharmacokinetics*
D009842:Oligopeptides; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; C057022:iturelix; D014805:Vitamin B 12